-
Liproxstatin-1 and Sex-Biased Ferroptosis
2026-09-02
Ferroptosis research is moving from pathway description toward causal, tissue-specific validation. This article examines how Liproxstatin-1 can help translational researchers test ferroptotic mechanisms in oxidative-stress models, including the sex-specific salivary gland phenotype reported in Sod1 knockout mice. It integrates mechanistic interpretation, experimental controls, formulation guidance, and strategic limitations while distinguishing evidence from renal injury models from hypotheses that remain untested in salivary dysfunction.
-
DNase I (RNase-free) for Clean RNA Workflows
2026-09-02
Build cleaner RNA extraction, RT-PCR, and in vitro transcription workflows with a calcium-dependent nuclease designed to remove DNA while preserving RNA quality. This guide combines practical reaction setup, cation-aware optimization, chromatin use cases, and troubleshooting with lessons from a protein-purification study.
-
HotStart Universal 2X Green qPCR Master Mix
2026-09-01
A scenario-based guide to using HotStart™ Universal 2X Green qPCR Master Mix, SKU K1170, for reproducible gene expression measurements alongside cell viability, proliferation, and cytotoxicity assays. It explains specificity controls, ROX compatibility, melt-curve interpretation, protocol design, and practical vendor-selection criteria.
-
Anti-M1R/B6R Antibodies for Orthopoxvirus Protection
2026-09-01
A 2025 study mapped antibody responses to the orthopoxvirus immunogens M1R and B6R and used those findings to build antibody cocktails and bispecific formats. Its strongest contribution is the demonstration that a VH-CH1 switch region-inserting bispecific design can provide robust protection against vaccinia virus in mice, while also clarifying the evidence needed for broader mpox therapeutic development.
-
Sodium Orthovanadate for Phospho-Signaling Assays
2026-08-31
Sodium Orthovanadate helps preserve labile tyrosine phosphorylation while supporting cleaner signaling, kinase, and enzyme workflows. This guide translates adipocyte insulin-signaling findings into practical preparation, assay-design, and troubleshooting decisions using reversible Na3VO4 inhibition.
-
Iron Stress Reprograms Enterocyte Metabolism
2026-08-31
Navazesh and Ji show that both iron deficiency and iron excess reshape enterocyte metabolism, but through distinct transcriptional and biochemical responses. Using IPEC-J2 cells, time-resolved gene-expression analysis, inflammatory stimulation, and untargeted metabolomics, the study links iron imbalance to impaired proliferation, altered energy metabolism, and partial recovery after iron repletion.
-
Erastin and the Redox Frontier of Ferroptosis
2026-08-30
Erastin is more than a standard ferroptosis inducer: it is a mechanistic probe for testing how RAS/BRAF-associated redox vulnerability translates into measurable tumor-cell death. This article connects pathway biology, experimental design, and translational interpretation while positioning Erastin as a benchmark for separating ferroptotic oxidative damage from other ROS-driven death programs.
-
AMPK–p62 Feedback Under Metabolic Stress
2026-08-29
The 2024 Autophagy study identifies a double-positive feedback loop linking AMPK and SQSTM1/p62 during metabolic stress. This circuit coordinates lysosomal signaling, KEAP1 degradation, NRF2 activation, and antioxidant defense, offering a mechanistic explanation for metabolic adaptation in STK11/LKB1- and KEAP1-altered lung cancer.
-
N1-Methylpseudouridine for Cardiac mRNA Studies
2026-08-28
Use N1-Methylpseudouridine to build higher-output, lower-inflammatory mRNA experiments around the HEY2–mitochondrial respiration axis. This practical guide combines mRNA translation enhancement with cardiac bioenergetics assays, controls, optimization ranges, and troubleshooting safeguards.
-
WEHI-539: Mapping BCL-XL Apoptotic Dependency
2026-08-28
WEHI-539 is a selective BCL-XL inhibitor for resolving mitochondrial apoptosis, MCL-1 compensation, and cancer stem cell sensitization. This article presents a dependency-mapping framework that connects molecular mechanism with assay design rather than repeating a conventional dosing workflow.
-
EdU Imaging Kits (488) for EV Bioprocessing
2026-08-27
Use EdU Imaging Kits (488) to quantify proliferating cells without DNA denaturation, making them practical for microscopy, flow cytometry, and bioreactor-based cell expansion studies. The workflow translates scalable iMSC extracellular-vesicle manufacturing into measurable S-phase quality checks while preserving morphology and compatible antigen-binding sites.
-
Cefoperazone Sodium Salt: Research Workflows
2026-08-27
Cefoperazone sodium salt supports reproducible antimicrobial screening, β-lactamase stability studies, and infection-model development when preparation and endpoint criteria are tightly controlled. This guide translates comparative β-lactam evidence into practical workflows for gram-negative resistance research and biliary tract infection research.
-
Spiroplasma Entry Pathways in Drosophila S2 Cells
2026-08-26
The reference study establishes Drosophila Schneider 2 cells as an experimentally tractable model for Spiroplasma eriocheiris infection and shows that bacterial entry depends mainly on clathrin-mediated endocytosis and macropinocytosis. Its inhibitor-based experiments further link intracellular infection to actin-filament and microtubule integrity, providing a useful framework for analyzing host–pathogen interactions in invertebrate cells.
-
AAPH for Controlled Oxidative Stress Assays
2026-08-26
AAPH provides a water-soluble, temperature-responsive source of peroxyl-radical stress for erythrocyte hemolysis, antioxidant screening, and protein oxidation studies. Its value is greatest when exposure is treated as a tunable experimental variable rather than a single fixed treatment, enabling direct comparison of lipid peroxidation, membrane injury, and functional-property changes.
-
LIRP: Light-Controlled RNA Release for Gene Therapy
2026-08-25
The reference study introduces a rationally designed light-inducible RNA-releasing protein that regulates therapeutic protein production at the translation stage, rather than relying only on transcriptional control. In mouse models, LIRP-enabled AAV2 systems supported light-responsive metabolic and retinal gene therapies, while also illustrating the remaining challenges of tissue illumination, dosing, and clinical translation.